TRENDS IN THE DEVELOPMENT OF NEW MEDICINES BY UK-OWNED PHARMACEUTICAL COMPANIES (1964-1980)

被引：13

作者：

PRENTIS, RA

WALKER, SR

机构：

来源：

关键词：

D O I：

10.1111/j.1365-2125.1986.tb05219.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：437 / 443

页数：7

共 13 条

[1]

DRURY VMM, 1978, TREATMENT HDB DRUG T

GRIFFIN, JP ;

DIGGLE, GE .

[3]

MATTISON N, 1984, Regulatory Toxicology and Pharmacology, V4, P157, DOI 10.1016/0273-2300(84)90038-2

[4]

PRENTIS RA, 1984, BRIT J CLIN PHARMACO, V18, pP303

[5]

RAVENSCROFT MK, 1983, BR J PHARM, V80, pP584

[6]

REISARNDT E, 1982, PHARM IND, V44, P1115

[7]

REISARNDT E, 1975, DRUGS MADE GERMANY, V118, P123

[8] DRUG INNOVATION - WHATS SLOWING IT DOWN [J].

STEWARD, F ;

WIBBERLEY, G .

[9]

WALKER SR, 1986, PHARM INT

[10]

WARDELL WM, 1980, J CLIN PHARMACOL, V20, P1